Investor Presentation slide image

Investor Presentation

AR 4Q22E AEBITDA annualized run-rate¹ 300 250 200 150 100 50 $104M A Q4 '21 Run-Rate Annualized AEBTIDA ~35% Cultivation Expansions ~30% Adult-Use Conversions ~12.5% M&A Closings ~12.5% Florida Enhancements ~10% Organic Growth ~$250M E Q4 '22 Run-Rate Annualized AEBITDA 1) Please refer to the "Forward-Looking Statements" and "Assumptions and Risks" detailed in the Company's press release dated May 26, 2022. The Company's expectations for future results, including the anticipated run-rate of $250M of Adjusted EBITDA, $100M of Operating Income and $800M of Revenue for Q4 2022, are based on the assumptions and risks detailed in the MD&A for the period ending March 31, 2022 as filed on SEDAR. 17
View entire presentation